Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
AusBiotech 2024AusBiotech 2024
Not Confirmed
Not Confirmed
30 October-02 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
AusBiotech 2024AusBiotech 2024
Industry Trade Show
Not Confirmed
30 October-02 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
29 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/29/2971208/20739/en/Ultragenyx-to-Host-Conference-Call-for-Third-Quarter-2024-Financial-Results-and-Corporate-Update.html
18 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/18/2965735/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
07 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/07/2958870/20739/en/Ultragenyx-Receives-Breakthrough-Therapy-Designation-for-Setrusumab-UX143-in-Osteogenesis-Imperfecta.html
04 Oct 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/ultragenyx-tweaks-gene-therapy-dosing-dial-efficacy-after-seeing-signs-activity
03 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/03/2958032/20739/en/Ultragenyx-Provides-Update-on-Stage-1-Cohorts-in-Pivotal-Phase-1-2-3-Cyprus2-Study-Evaluating-UX701-Gene-Therapy-for-the-Treatment-of-Wilson-Disease.html
26 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/26/2953729/0/en/INKmune-Demonstrates-Excellent-Safety-and-Increased-NK-Cell-Activity-in-First-Dosing-Cohort.html
ABOUT THIS PAGE
Ultragenyx Pharmaceutical is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Triheptanoin bulk with DMF offered by Ultragenyx Pharmaceutical
LOOKING FOR A SUPPLIER?